Skip to content

Comparison of Oxygen Saturation Measurements Using Different Glove Colors in Children

Comparison of Oxygen Saturation Measurements Using Different Glove Colors in Children: A Preventive Method for Infection?

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06626763
Enrollment
68
Registered
2024-10-04
Start date
2024-10-08
Completion date
2025-10-08
Last updated
2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Infection, Oxygen Saturation

Brief summary

The aim of this study was to determine the effect of different colored gloves on oxygen saturation in pediatric patients whose oxygen saturation was measured by pulse oximetry in pediatric emergency department. The population of the study, which is planned as a prospective cohort study, will consist of children between the ages of 3-18 years who underwent oxygen saturation measurements in the pediatric emergency clinic of İzmir Bakırçay University Cigli and Training and Research Hospital between October 2024 and October 2025.

Detailed description

The aim of this study was to determine the effect of different colored gloves on oxygen saturation in pediatric patients who underwent oxygen saturation measurement by pulse oximetry in pediatric emergency department. The population of the study, which is planned as a prospective cohort study, will consist of children aged 3-18 years who underwent oxygen saturation measurements in the pediatric emergency clinic of İzmir Bakırçay University Çiğli and Training and Research Hospital between October 2024 and October 2025. The sample of the study will consist of children who meet the inclusion criteria on the specified dates and whose parents/legal guardians agree to participate in the study. Descriptive Characteristics Form and Oxygen Saturation Measurement Value Record Form will be used for data collection.

Interventions

None listed

Sponsors

Izmir Katip Celebi University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Children between the ages of 3-18, * The parent/legal guardian or the child himself/herself agrees to participate in the study, * Arterial blood gas measurement was performed,

Exclusion criteria

* The finger has a skin condition, * Having nail polish on your fingernails, * Having a severed finger,

Design outcomes

Primary

MeasureTime frameDescription
Measuring the arterial blood gas SpO2 saturationProcedureFinger SpO2 measurements will be initiated as soon as the blood gas measurement process starts. Pulse oximetry measurements and intra-arterial blood gas measurements will be performed
without gloves measuring the SpO2 saturationWhile the patient was not wearing gloves, the pulse oximeter light source was placed on the outer surface of the finger. SpO2 was read after waiting an average of 30 seconds.
SpO2 saturation measurement with transparent colored gloveWhile the patient was wearing a transparent glove, the pulse oximeter light source was placed on the outer surface of the finger. SpO2 was read after waiting an average of 30 seconds.
SpO2 saturation measurement with white colored gloveWhile the patient was wearing a white glove, the pulse oximeter light source was placed on the outer surface of the finger. SpO2 was read after waiting an average of 30 seconds.
SpO2 saturation measurement with black colored gloveWhile the patient was wearing a black glove, the pulse oximeter light source was placed on the outer surface of the finger. SpO2 was read after waiting an average of 30 seconds.
SpO2 saturation measurement with blue colored gloveWhile the patient was wearing a blue glove, the pulse oximeter light source was placed on the outer surface of the finger. SpO2 was read after waiting an average of 30 seconds.

Countries

Turkey (Türkiye)

Contacts

Primary ContactEliz Geçtan
elizgectan09@gmail.com05451342435

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026